We experienced 13 cases (29.8 ± 7.0 years) of mumps meningitis and 365 cases of adult aseptic meningitis during 11 years from 2004 to 2014. A small epidemic of mumps occurred for 3-4 years, and the incidence rate of adult mumps meningitis coincided with the epidemic without seasonal fluctuation. Parotitis was observed in 8 of the 13 mumps meningitis patients (61.5%) and orchitis in 2 of 7 male patients (28.6%). There were no differences in clinical manifestations, laboratory findings, and outcome between patients with adult mumps meningitis and those with echovirus 9 meningitis (9 patients), except for the low frequency of nausea/vomiting and a high percentage of mononuclear cells of the cerebrospinal fluid in those with mumps. Eight patients had contact with persons with mumps before the symptomatic stage of meningitis. Only one patient had received mumps vaccination in childhood. On the basis of the values of the anti-mumps IgM and IgG antibodies, we speculated primary infection and the re-infection of mumps in 6 and 2 patients, respectively. Moreover, second vaccine failure was suggested in the vaccinated patient.

Download full-text PDF

Source
http://dx.doi.org/10.5692/clinicalneurol.cn-000718DOI Listing

Publication Analysis

Top Keywords

mumps meningitis
16
mumps
10
adult aseptic
8
meningitis
8
aseptic meningitis
8
adult mumps
8
meningitis patients
8
mumps patients
8
patients
6
[clinical epidemiological
4

Similar Publications

A patient with a history of Asian flu, mumps meningo-encephalitis, and skull-base fracture and severe porencephaly who was able to walk without assistance, has not been reported. The patient is a 65 year-old male with a history of Asian flu at 6 months of age, Mumps meningoencephalitis at 6 years of age, structural epilepsy since 15 years of age, traumatic brain injury with skull-base fracture at 51 years of age, arterial hypertension, diabetes, hyperlipidemia, previous alcoholism, and polyneuropathy. He presented with only mild right-sided spastic hemiparesis, dysarthria, decreased tendon reflexes in the lower limbs, spastic-ataxic gait, but he was able to walk unassisted.

View Article and Find Full Text PDF

We present a case of a 12-year-old healthy girl who presented with acute onset of dry, hyperpigmented, and raised pruritic rash. The lesions initially presented on her thighs then progressed to the trunk and arms hours after receiving the tetanus-diphtheria-pertussis (Tdap) and meningococcal vaccine. After a poor response to medium potency topical steroids, a biopsy specimen was taken, which led to our diagnosis.

View Article and Find Full Text PDF

Atypical Mumps; are We Heading Towards an Outbreak?

Indian J Otolaryngol Head Neck Surg

October 2024

AIIMS, Bhubneshwar, India.

Article Synopsis
  • Mumps is a contagious disease mainly affecting children and young adults, characterized by salivary gland swelling and potential serious complications like SNHL, orchitis, and meningitis.
  • A recent study conducted in five medical centers across India examined 53 patients with acute salivary gland swelling, revealing a bimodal age distribution and significant symptoms such as fever and gland involvement.
  • The findings indicate a concerning trend of mumps affecting older individuals with increased complications post-COVID-19, highlighting issues related to vaccination, immunity, and the potential for outbreaks in the future.
View Article and Find Full Text PDF
Article Synopsis
  • Mumps is a viral infection characterized by fever and swelling of the parotid glands, caused by the paramyxovirus.
  • Complications from mumps can include aseptic meningitis, encephalitis, oophoritis, orchitis, and pancreatitis.
  • The rising incidence of mumps in Nepal highlights the need to include mumps vaccination in the national immunization schedule.
View Article and Find Full Text PDF

Introduction: Mumps data were analysed to assess the effect of vaccination on mumps complications and hospitalisation.

Methods: The mumps cases reported to the Czech nationwide surveillance system from 2013 to 2022 were analysed using logistic regression with an odds ratio (aOR) adjusted for age, sex, year of onset and administrative region to measure the association between vaccination and complications or hospitalisation. Adjusted vaccine effectiveness (aVE) was calculated: aVE=(1-aOR)x100.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!